Transcell Oncologics has dedicated team working on

Hunting for undruggable challenging targets in cancers for druggable molecules

Elucidating novel mechanistic pathways leading to known targets modulated by small molecules

Drug discovery from the insights of cancer genomics

As a stem cell based biotech company, we uniquely leverage our distinct insights from adult stem cells sourced from patients samples, donor samples, predictive stem cell technologies to discover the anti-cancer stem/cell properties, hunting for druggable molecules that selectively kill cancer stem cells. The data on human/patient based platforms/models, Genomics and Proteomics aid to advance our pipeline to clinical proof of concept and discovery of functional molecules. Access to all new nature inspired complex macrocyclic small molecules along with the wisdom derived from the stem cell technologies are our differentiating positioning in this space accelerating the process of drug discovery in Oncology.

R & D Team

S Dravida, PhD

S Dravida leads the team and collaborations responsible for discovering druggable formulations across therapeutic areas and platforms. Her role requires converging and executing both laboratory, clinical research programs across touch points.

Past Affiliations:

University of North Carolina, Ottawa Health Research Institute,

Center for Cellular and Molecular Biology, Hyderabad Eye Research Foundation.